A Rare Case of Intra-Endometrial Leiomyoma of Uterus Simulating Degenerated Submucosal Leiomyoma Accompanied by a Large Sertoli-Leydig Cell Tumor.
10.3349/ymj.2016.57.2.523
- Author:
Kyungah JEONG
1
;
Sa Ra LEE
;
Sanghui PARK
Author Information
1. Department of Obstetrics and Gynecology, Ewha Womans University School of Medicine, Seoul, Korea. sarahmd@ewha.ac.kr
- Publication Type:Case Reports
- Keywords:
Sertoli-Leydig cell tumor;
intra-endometrial leiomyoma;
submucosal myoma;
heavy menstrual bleeding
- MeSH:
Adenomyosis/*diagnosis/drug therapy;
Carboplatin/therapeutic use;
Female;
Humans;
Laparoscopy;
Leiomyoma/*diagnosis/drug therapy;
Male;
Menorrhagia;
Middle Aged;
Neoplasm Recurrence, Local;
Paclitaxel/therapeutic use;
Sertoli-Leydig Cell Tumor/*diagnosis/drug therapy;
Treatment Outcome;
Uterine Neoplasms/*diagnosis/drug therapy
- From:Yonsei Medical Journal
2016;57(2):523-526
- CountryRepublic of Korea
- Language:English
-
Abstract:
A 50-year-old peri-menopausal woman presented with hard palpable mass on her lower abdomen and anemia from heavy menstrual bleeding. Ultrasonography showed a 13x12 cm sized hypoechoic solid mass in pelvis and a 2.5x2 cm hypoechoic cystic mass in uterine endometrium. Abdomino-pelvic computed tomography revealed a hypodense pelvic mass without enhancement, suggesting a leiomyoma of intraligamentary type or sex cord tumor of right ovary with submucosal myoma of uterus. Laparoscopy revealed a large Sertoli-Leydig cell tumor of right ovary with a very rare entity of intra-endometrial uterine leiomyoma accompanied by adenomyosis. The final diagnosis of ovarian sex-cord tumor (Sertoli-Leydig cell), stage Ia with intra-endometrial leiomyoma with adenomyosis, was made. Considering the large size of the tumor and poorly differentiated nature, 6 cycles of chemotherapy with Taxol and Carboplatin regimen were administered. There is neither evidence of major complications nor recurrence during 20 months' follow-up.
